Devyser and Thermo Fisher Scientific collaborate to promote laboratory services to advance pharmaceutical research
Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote...
Hereditary cancer | September 30, 2022
Contact an expert at Devyser
If you have a question, feel free to send us a message. One of our team members will get in touch with you as soon as possible.
Devyser and Thermo Fisher Scientific expand the collaboration for post-transplant NGS products by adding Brazil
Devyser and Thermo Fisher Scientific have agreed to expand commercial collaboration by including...
Devyser’s NGS products for monitoring of kidney and stem cell transplant patients receive IVDR approvals
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
Devyser has inaugurated its CLIA-certified laboratory and performed the first patient fetal RhD test
Devyser has inaugurated its CLIA-certified laboratory in Atlanta, Georgia. The laboratory will...